Sensory Processing Dysfunction

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Maxwell Biosciences
1 program
Sensory Processing Difficulties in Adults and AdolescentsN/A1 trial
Active Trials
NCT02205658Unknown1,300Est. Dec 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Maxwell BiosciencesSensory Processing Difficulties in Adults and Adolescents

Clinical Trials (1)

Total enrollment: 1,300 patients across 1 trials

NCT02205658Maxwell BiosciencesSensory Processing Difficulties in Adults and Adolescents

Sensory Processing Difficulties in Adults and Adolescents

Start: Jan 2014Est. completion: Dec 20141,300 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space